Overall rank by patents
#2,566
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
SOFRADIM PRODUCTION
USPTO PatentsView assignee record — 152 granted patents across 46 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
152
Total patents granted
46
CPC technology areas
18.6
Avg claims per patent
-15%
5-year filing velocity
Portfolio overview
SOFRADIM PRODUCTION has been granted 152 US utility patents between 2015 and 2025, placing SOFRADIM PRODUCTION at rank #2,566 across all assignees tracked by PlainPatent. This portfolio spans 46 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, SOFRADIM PRODUCTION is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 58.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 70 grants, compared with 82 in the 2015–2019 window — a -15% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SOFRADIM PRODUCTION's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 46 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SOFRADIM PRODUCTION against peers pursuing similar technology classes.
How does SOFRADIM compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Sofradim Producti… ◀ 152
SOFRADIM PRODUCTION
152 patents
What this shows SOFRADIM holds 152 patents — placing it at rank #2,566 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 13 | 8.6% |
| 2016 | 21 | 13.8% |
| 2017 | 14 | 9.2% |
| 2018 | 18 | 11.8% |
| 2019 | 16 | 10.5% |
| 2020 | 18 | 11.8% |
| 2021 | 8 | 5.3% |
| 2022 | 12 | 7.9% |
| 2023 | 12 | 7.9% |
| 2024 | 13 | 8.6% |
| 2025 | 7 | 4.6% |
Which technologies does SOFRADIM PRODUCTION patent most?
Top 15 of 46 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does SOFRADIM PRODUCTION hold?
SOFRADIM PRODUCTION holds 152 US granted patents filed between 2015 and 2025, spanning 46 technology areas.
What is SOFRADIM PRODUCTION's Innovation Score?
SOFRADIM PRODUCTION has an Innovation Score of 58.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does SOFRADIM PRODUCTION focus on?
SOFRADIM PRODUCTION's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 105 patents. The company has filed patents in 46 CPC subclasses total.
Is SOFRADIM PRODUCTION's patent filing rate increasing or decreasing?
SOFRADIM PRODUCTION's recent filing velocity is -15% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for SOFRADIM PRODUCTION's patents?
SOFRADIM PRODUCTION's patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the SOFRADIM PRODUCTION patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61F technology
SOFRADIM PRODUCTION's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where SOFRADIM PRODUCTION ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
